Mechanisms by which common variants in the TCF7L2 gene increase risk of type 2 diabetes.
about
Decreased TCF7L2 protein levels in type 2 diabetes mellitus correlate with downregulation of GIP- and GLP-1 receptors and impaired beta-cell functionTCF7L2 regulates late events in insulin secretion from pancreatic islet beta-cellsA high-coverage genome sequence from an archaic Denisovan individualPhysiologic characterization of type 2 diabetes-related lociTranscription factor 7-like 2 polymorphism and colon cancerPharmacogenetic studies update in type 2 diabetes mellitusGenetics of Insulin Resistance and the Metabolic SyndromeNovel phenotypes of prediabetes?Dissecting diabetes/metabolic disease mechanisms using pluripotent stem cells and genome editing toolsThe association between the rs11196218A/G polymorphism of the TCF7L2 gene and type 2 diabetes in the Chinese Han population: a meta-analysisCell-context dependent TCF/LEF expression and function: alternative tales of repression, de-repression and activation potentialsUsing gene-network landscape to dissect genotype effects of TCF7L2 genetic variant on diabetes and cardiovascular riskPolymorphism of the Transcription Factor 7-Like 2 Gene (TCF7L2) Interacts with Obesity on Type-2 Diabetes in the PREDIMED Study Emphasizing the Heterogeneity of Genetic Variants in Type-2 Diabetes Risk Prediction: Time for Obesity-Specific Genetic RDifferential methylation of TCF7L2 promoter in peripheral blood DNA in newly diagnosed, drug-naïve patients with type 2 diabetesTCF7L2 modulates glucose homeostasis by regulating CREB- and FoxO1-dependent transcriptional pathway in the liverHuman-specific derived alleles of CD33 and other genes protect against postreproductive cognitive declineEvaluation of fasting state-/oral glucose tolerance test-derived measures of insulin release for the detection of genetically impaired β-cell functionGenome-wide association studies in type 2 diabetesTransferability of type 2 diabetes implicated loci in multi-ethnic cohorts from Southeast AsiaGenetic variation in GIPR influences the glucose and insulin responses to an oral glucose challengeA novel TCF7L2 type 2 diabetes SNP identified from fine mapping in African American women.Bridging the gap between genetic associations and molecular mechanisms for type 2 diabetes.Nutrigenetics and nutrigenomics insights into diabetes etiopathogenesis.Association of fibrillin-3 and transcription factor-7-like 2 gene variants with metabolic phenotypes in PCOS.Islet specific Wnt activation in human type II diabetes.Data interpretation: deciphering the biological function of Type 2 diabetes associated risk loci.TCF7L2 polymorphism rs7903146 is associated with coronary artery disease severity and mortalityThe genetic susceptibility to type 2 diabetes may be modulated by obesity status: implications for association studies.Weak or no association of TCF7L2 variants with Type 2 diabetes risk in an Arab population.TCF7L2 variant genotypes and type 2 diabetes risk in Brazil: significant association, but not a significant tool for risk stratification in the general population.Adiposity-related heterogeneity in patterns of type 2 diabetes susceptibility observed in genome-wide association dataAlternative splicing of TCF7L2 gene in omental and subcutaneous adipose tissue and risk of type 2 diabetes.Large effects on body mass index and insulin resistance of fat mass and obesity associated gene (FTO) variants in patients with polycystic ovary syndrome (PCOS).Combined risk allele score of eight type 2 diabetes genes is associated with reduced first-phase glucose-stimulated insulin secretion during hyperglycemic clamps.β-cell mass in people with type 2 diabetes.TCF7L2 polymorphism associates with new-onset diabetes after transplantation.Genetics of type 2 diabetes: insights into the pathogenesis and its clinical application.TCF7L2 variant rs7903146 affects the risk of type 2 diabetes by modulating incretin action.Type 2 diabetes susceptibility gene expression in normal or diabetic sorted human alpha and beta cells: correlations with age or BMI of islet donors.Differential transcriptional and posttranslational transcription factor 7-like regulation among nondiabetic individuals and type 2 diabetic patients.
P2860
Q24318496-E8CC1D13-9206-455A-BE8A-EB7106E07DDDQ24321979-7F8BA481-AB52-4037-9107-88BC1A952441Q24595378-0A065C95-9352-4378-9D19-20BAC3CE0E8AQ24630735-AC7BA149-97B9-419F-A259-7CFA242E0615Q24654061-83A58781-4BDB-47AC-9E04-07E12D76B0A6Q26739350-0FF73C0B-784F-4418-8C5C-98E6E93542E3Q26745624-784B6ED3-E9ED-4E9F-BDC0-814E494312E2Q26747128-D1B23177-F6AD-4FFC-94AE-E20487630902Q26785684-AC728388-26BF-4977-864A-E45882ED5C64Q26801544-0F7EB01C-F53F-4BBC-B050-18095BDA36A5Q27022532-2A51991F-A15A-4297-932E-0047695E4F55Q28272656-4774AA85-0E23-40FC-9BA6-0DEAEACF7838Q28354290-E6F8A9D0-7A0E-46FA-A2F7-EF2A30677A33Q28539538-B218EB95-3A2A-47B7-A70C-17FF5E779C3CQ28589957-F286139F-C7A8-43BE-81BA-E4FC27135F47Q28602637-71A924FB-C995-4E98-B55E-C74716DD057AQ28744489-D172A5A9-CF26-487B-AB25-DBEC92D92B7CQ28752564-538DA363-19DD-4073-84D3-F86F7FE56D57Q28943320-6B0237A9-D9DE-4C9B-AB44-06E61801E256Q29147442-B66E91B4-8031-45A6-8951-D72423FD86F5Q30353711-F52C56BF-97A2-40C7-BBBA-9E55298C7BF1Q30354544-18D62BDC-F85F-42D2-8883-8B39C3FFF4D0Q30368908-A186056A-DB1F-4380-95C6-72108AD26EA6Q30423757-732BABA0-269C-4BCE-B57E-957A395F1C77Q30485515-05398478-0F83-4EA6-A552-8AA49F6A3215Q30884322-16766072-328F-4AE8-838C-51848A1BFE07Q30895121-A66A5C0C-9E79-41A5-8A1A-A8F4BD0D67A8Q33337217-54CAC09F-CDE4-4657-9FAC-1A1D4424E6DAQ33355188-B998BDE7-5BC6-4C45-93BE-70654914B82FQ33389614-153808C3-B1D1-453F-BB0E-A5A325483859Q33389729-409506DF-3761-4E4F-8317-DE6163258253Q33507522-74DAF0A0-1F3F-4601-8094-670E522E9C2CQ33525709-B20E3E6C-9ECC-40E0-B465-35BB88D91178Q33556613-4D5ED9C1-8C3D-4E5E-9E73-F73752529460Q33558395-E942C100-A0CA-4734-86D0-5DD95686A4CAQ33561720-13EFA91F-F167-4D2E-9FF6-5EB7BA0B3774Q33593963-E9EA9C73-A6F3-4213-9285-179D4BB10A82Q33604496-B392BB30-EDBA-44F4-80F4-67DE9FA33717Q33604681-98A679B6-1841-4249-9825-4EA7811BB7CCQ33631948-6C4922DB-7DB3-4DB3-ACFA-F9EF1599C348
P2860
Mechanisms by which common variants in the TCF7L2 gene increase risk of type 2 diabetes.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Mechanisms by which common variants in the TCF7L2 gene increase risk of type 2 diabetes.
@ast
Mechanisms by which common variants in the TCF7L2 gene increase risk of type 2 diabetes.
@en
type
label
Mechanisms by which common variants in the TCF7L2 gene increase risk of type 2 diabetes.
@ast
Mechanisms by which common variants in the TCF7L2 gene increase risk of type 2 diabetes.
@en
prefLabel
Mechanisms by which common variants in the TCF7L2 gene increase risk of type 2 diabetes.
@ast
Mechanisms by which common variants in the TCF7L2 gene increase risk of type 2 diabetes.
@en
P2093
P2860
P50
P356
P1476
Mechanisms by which common variants in the TCF7L2 gene increase risk of type 2 diabetes.
@en
P2093
Asa-Linda Lethagen
Göran Berglund
Karl-Fredrik Eriksson
Marketa Sjögren
Peter Almgren
Peter Nilsson
Rita Mancarella
Roberto Lupi
P2860
P304
P356
10.1172/JCI30706
P407
P50
P577
2007-08-01T00:00:00Z